{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T16:01:24Z","timestamp":1780243284494,"version":"3.54.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,31]]},"DOI":"10.7759\/cureus.109973","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T15:24:34Z","timestamp":1780241074000},"source":"Crossref","is-referenced-by-count":0,"title":["Rose Stem Cell-Derived Exosome-Hyaluronic Acid Therapy for Recurrent Atrophic Vaginitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Marwa H","family":"Elajami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2019.1600499","article-title":"Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy","volume":"22","author":"Palacios S","year":"2019","unstructured":"Palacios S. Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy. Climacteric. 2019, 22:348-51. 10.1080\/13697137.2019.1600499","journal-title":"Climacteric"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1529748","article-title":"Vaginal atrophy across the menopausal age: results from the ANGEL study","volume":"22","author":"Cagnacci A","year":"2019","unstructured":"Cagnacci A, Xholli A, Sclauzero M, Venier M, Palma F, Gambacciani M. Vaginal atrophy across the menopausal age: results from the ANGEL study. Climacteric. 2019, 22:85-9. 10.1080\/13697137.2018.1529748","journal-title":"Climacteric"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2015.09.001","article-title":"Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study","volume":"83","author":"Palma F","year":"2016","unstructured":"Palma F, Volpe A, Villa P, Cagnacci A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas. 2016, 83:40-4. 10.1016\/j.maturitas.2015.09.001","journal-title":"Maturitas"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.975199","article-title":"The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy","volume":"18","author":"Nappi RE","year":"2015","unstructured":"Nappi RE, Panay N, Bruyniks N, Castelo-Branco C, De Villiers TJ, Simon JA. The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. Climacteric. 2015, 18:233-40. 10.3109\/13697137.2014.975199","journal-title":"Climacteric"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.05.002","article-title":"Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women","volume":"229","author":"Tan-Kim J","year":"2023","unstructured":"Tan-Kim J, Shah NM, Do D, Menefee SA. Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. Am J Obstet Gynecol. 2023, 229:143.e1-9. 10.1016\/j.ajog.2023.05.002","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/sm2.17","article-title":"Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women","volume":"1","author":"Goldstein I","year":"2013","unstructured":"Goldstein I, Dicks B, Kim NN, Hartzell R. Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women. Sex Med. 2013, 1:44-53. 10.1002\/sm2.17","journal-title":"Sex Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-019-00700-w","article-title":"Practical treatment considerations in the management of genitourinary syndrome of menopause","volume":"36","author":"Kagan R","year":"2019","unstructured":"Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019, 36:897-908. 10.1007\/s40266-019-00700-w","journal-title":"Drugs Aging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01354.x","article-title":"Atrophic vaginitis","volume":"23","author":"Stika CS","year":"2010","unstructured":"Stika CS. Atrophic vaginitis. Dermatol Ther. 2010, 23:514-22. 10.1111\/j.1529-8019.2010.01354.x","journal-title":"Dermatol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205302","article-title":"Delivering umbilical cord mesenchymal stem cell exosomes through hydrogel ameliorates vaginal atrophy in ovariectomized rats","volume":"15","author":"Zhang T","year":"2023","unstructured":"Zhang T, Li D, Wang Y, Zhang C, Yang W, Gao G. Delivering umbilical cord mesenchymal stem cell exosomes through hydrogel ameliorates vaginal atrophy in ovariectomized rats. Aging (Albany NY). 2023, 15:14292-305. 10.18632\/aging.205302","journal-title":"Aging (Albany NY)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002393","article-title":"Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial","volume":"31","author":"Dell'Utri CM","year":"2024","unstructured":"Dell'Utri CM, Manzoni E, Bonfanti I, Marrocco F, Barbara G, Pifarotti P, Chiaffarino F. Should I stay for local hormone therapy or should I go for radiofrequency to treat vulvovaginal atrophy? A patient preference trial. Menopause. 2024, 31:801-8. 10.1097\/GME.0000000000002393","journal-title":"Menopause"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro N","year":"2009","unstructured":"Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009, 6:2133-42. 10.1111\/j.1743-6109.2009.01335.x","journal-title":"J Sex Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride MB","year":"2010","unstructured":"Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010, 85:87-94. 10.4065\/mcp.2009.0413","journal-title":"Mayo Clin Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.08.019","article-title":"Genitourinary syndrome of menopause: management strategies for the clinician","volume":"92","author":"Faubion SS","year":"2017","unstructured":"Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc. 2017, 92:1842-9. 10.1016\/j.mayocp.2017.08.019","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1446930","article-title":"The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause","volume":"21","author":"Palacios S","year":"2018","unstructured":"Palacios S, Nappi RE, Bruyniks N, Particco M, Panay N. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric. 2018, 21:286-91. 10.1080\/13697137.2018.1446930","journal-title":"Climacteric"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000526","article-title":"Vaginal estrogen for genitourinary syndrome of menopause: a systematic review","volume":"124","author":"Rahn DD","year":"2014","unstructured":"Rahn DD, Carberry C, Sanses TV, et al.. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014, 124:1147-56. 10.1097\/AOG.0000000000000526","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson JE","year":"2013","unstructured":"Manson JE, Chlebowski RT, Stefanick ML, et al.. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013, 310:1353-68. 10.1001\/jama.2013.278040","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?","volume":"19","author":"Edwards D","year":"2016","unstructured":"Edwards D, Panay N. Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?. Climacteric. 2016, 19:151-61. 10.3109\/13697137.2015.1124259","journal-title":"Climacteric"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.10.016","article-title":"Hyaluronic acid in postmenopause vaginal atrophy: a systematic review","volume":"18","author":"Dos Santos CC","year":"2021","unstructured":"Dos Santos CC, Uggioni ML, Colonetti T, Colonetti L, Grande AJ, Da Rosa MI. Hyaluronic acid in postmenopause vaginal atrophy: a systematic review. J Sex Med. 2021, 18:156-66. 10.1016\/j.jsxm.2020.10.016","journal-title":"J Sex Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44191","article-title":"Comparison of the efficacy of vaginal hyaluronic acid to estrogen for the treatment of vaginal atrophy in postmenopausal women: a systematic review","volume":"15","author":"Albalawi NS","year":"2023","unstructured":"Albalawi NS, Almohammadi MA, Albalawi AR. Comparison of the efficacy of vaginal hyaluronic acid to estrogen for the treatment of vaginal atrophy in postmenopausal women: a systematic review. Cureus. 2023, 15:e44191. 10.7759\/cureus.44191","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/452869-rose-stem-cell-derived-exosome-hyaluronic-acid-therapy-for-recurrent-atrophic-vaginitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T15:24:35Z","timestamp":1780241075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/452869-rose-stem-cell-derived-exosome-hyaluronic-acid-therapy-for-recurrent-atrophic-vaginitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.109973","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}